IN8bio, Inc. Common Stock (NASDAQ: INAB) last traded at $1.23, down 8.21% on the session. The quote above updates while this page is open; the figures below are drawn from IN8bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
IN8bio, Inc. Common Stock trades on NASDAQ under the ticker INAB. Its market capitalisation is $12.13 million.
Valuation measures for IN8bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $12.13M |
|---|---|
| Enterprise value | -$2.62M |
| Price / book | 0.66 |
| Beta | 1.37 |
Trailing-twelve-month figures tagged in IN8bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$18.67M |
| EPS (TTM) | -$1.55 |
|---|
| Return on equity | -101.66% |
|---|
| Cash | $18.13M |
|---|
Range and volume for INAB over the past 52 weeks.
| 52-week high | $2.73 |
|---|---|
| 52-week low | $0.880 |
| Volume | 31.8K |
| Average volume | 56.8K |
| Previous close | $1.34 |
Invest a chosen dollar amount in IN8bio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell INAB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.